This topic contains a solution. Click here to go to the answer

Author Question: Patients need to be questioned about all pain sites because: 1. Patients tend to report the most ... (Read 10 times)

chads108

  • Hero Member
  • *****
  • Posts: 507
Patients need to be questioned about all pain sites because:
 
  1. Patients tend to report the most severe or important in their perception.
  2. Pain tolerance generally decreases with repeated exposure.
  3. The reported pain site is usually the most important to treat.
  4. Pain may be referred from a different site to the one reported.

Question 2

The chemicals that promote the spread of pain locally include:
 
  1. Serotonin
  2. Norepinephrine
  3. Enkephalin
  4. Neurokinin A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

mammy1697

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

1

Answer to Question 2

4




chads108

  • Member
  • Posts: 507
Reply 2 on: Jul 24, 2018
YES! Correct, THANKS for helping me on my review


LVPMS

  • Member
  • Posts: 323
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Every 10 seconds, a person in the United States goes to the emergency room complaining of head pain. About 1.2 million visits are for acute migraine attacks.

Did you know?

Acute bronchitis is an inflammation of the breathing tubes (bronchi), which causes increased mucus production and other changes. It is usually caused by bacteria or viruses, can be serious in people who have pulmonary or cardiac diseases, and can lead to pneumonia.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library